Inventiva is a startup based in France, most recent round Series-c-plus, 2 tracked investors.
Inventiva is a startup founded in 2012 based in France. Its most recent tracked round is Series-c-plus. Brouky records 2 investors associated with the company.
Inventiva is a clinical-stage biopharmaceutical company that develops oral small molecule therapies for diseases with significant unmet medical needs, including fibrosis, lysosomal storage disorders, and oncology. Its lead product, lanifibranor, is in Phase 3 clinical trials for metabolic dysfunction-associated steatohepatitis (MASH/NASH).
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.